Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Printing apparatus and method of operation of a printing apparatus
(-)-epigallocatechin gallate derivatives for inhibiting proteasome
Automated measurement of concentration and/or amount in a biological sample
System and method for investing public deposits
Build process management system
Method and system for constructing a customized web analytics application
Selecting modulation and coding scheme in the presence of interference
  Randomly Featured Patents
Method for automatic trap selection for correcting for separation misregistration in color printing
Vehicular suspension device
Electron-optical system with variable-shaped beam for generating and measuring microstructures
Digital filter circuit and data processing method
Solid-state image pickup device
Airline telephone handset with digital passenger control functions and video game controls
Illuminated display assembly
Plastic compositions
Video apparatus and method for controlling the same
Collapsible bird feeder